19 studies found for:    "Lupus Erythematosus, Discoid"
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo
2 Terminated Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva
Condition: Discoid Lupus Erthematosus of the Scalp.
Intervention: Drug: Raptiva (efalizumab)
3 Terminated Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Conditions: Cutaneous Lupus;   Discoid Lupus;   Lupus;   Systemic Lupus Erythematosus
Interventions: Drug: AMG811;   Drug: AMG811 Placebo
4 Terminated A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus
Condition: Discoid Lupus
Interventions: Drug: CC-930;   Drug: Placebo
5 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
6 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream applied twice daily;   Drug: Cream vehicle for ASF 1096 cream applied twice daily
7 Completed A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Intervention: Drug: Thalidomide
8 Unknown  The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus (DLE)
Intervention: Drug: etanercept(Enbrel®)
9 Completed Efficacy and Safety of ASF-1096 Cream 0.5% in the Treatment of Discoid Lupus Erythematosus (DLE) Lesions (2)
Condition: Discoid Lupus Erythematosus
Interventions: Drug: ASF 1096 0.5 % cream;   Drug: ASF 1096 placebo cream
10 Unknown  Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
11 Completed Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
Condition: Discoid Lupus Erythematosus
Intervention: Drug: CC-10004
12 Not yet recruiting Pilot Tape Harvesting Study
Conditions: Healthy;   Lupus Erythematosus, Discoid
Interventions: Procedure: Skin Taping;   Procedure: Blood Sampling;   Procedure: Skin Biopsy
13 Completed A Non-drug Study Profiling Cutaneous Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid
Interventions: Procedure: No intervention, skin biopsy;   Procedure: No intervention, blood collection;   Procedure: No intervention, urine collection
14 Recruiting A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
15 Completed A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies
Condition: Lupus Erythematosus, Discoid
Interventions: Drug: Belimumab 1 mg/kg;   Drug: Belimumab 10 mg/kg;   Other: Placebo
16 Not yet recruiting Phase Ib Study of SC Milatuzumab in SLE
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic;   Lupus Vasculitis, Central Nervous System;   Lupus Nephritis
Intervention: Drug: milatuzumab
17 Completed To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: CC-11050
18 Active, not recruiting Expression of Fas Protein in Skin Biopsies of Participants With Scarring Alopecia
Conditions: Central Centrifugal Scarring Alopecia;   Lichen Planopilaris;   Discoid Lupus Erythematosus
Intervention:
19 Terminated Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Condition: Lupus Erythematosus, Cutaneous
Intervention: Drug: Alitretinoin

Indicates status has not been verified in more than two years